Atlas Trials

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Clinical trial NCT02363829 · COMPLETED

Trial details

NCT number
NCT02363829
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Uterine Cervix Cancer
Start date
2015-02-01
Primary completion
2020-02-17
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.